Rimiterol

Chemical compound
  • AU: A
ATC code
  • R03AC05 (WHO)
Legal statusLegal status
  • AU: S4 (Prescription only)
Identifiers
  • 4-{(S)-hydroxy[(2R)-piperidin-2-yl]methyl}benzene-1,2-diol
CAS Number
  • 32953-89-2 ☒N
PubChem CID
  • 36283
ChemSpider
  • 33366 checkY
UNII
  • 26GIW6ZLPH
ChEMBL
  • ChEMBL1097630 ☒N
CompTox Dashboard (EPA)
  • DTXSID70186603 Edit this at Wikidata
ECHA InfoCard100.046.627 Edit this at WikidataChemical and physical dataFormulaC12H17NO3Molar mass223.272 g·mol−13D model (JSmol)
  • Interactive image
  • O[C@@H](c1ccc(O)c(O)c1)[C@@H]2NCCCC2
InChI
  • InChI=1S/C12H17NO3/c14-10-5-4-8(7-11(10)15)12(16)9-3-1-2-6-13-9/h4-5,7,9,12-16H,1-3,6H2/t9-,12+/m1/s1 checkY
  • Key:IYMMESGOJVNCKV-SKDRFNHKSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Rimiterol (INN/USAN) is a third-generation[1] short-acting[2][3] β2 agonist.

See also

  • Isoprenaline
  • Colterol

References

  1. ^ Palma-Carlos AG, Palma-Carlos GS (April 1986). "Beta-2-agonists of third generation". Allergie et Immunologie. 18 (4): 31–2, 35. PMID 2899434.
  2. ^ Lai CK, Twentyman OP, Holgate ST (October 1989). "The effect of an increase in inhaled allergen dose after rimiterol hydrobromide on the occurrence and magnitude of the late asthmatic response and the associated change in nonspecific bronchial responsiveness". The American Review of Respiratory Disease. 140 (4): 917–23. doi:10.1164/ajrccm/140.4.917. PMID 2572192.
  3. ^ Ydreborg SO, Svedmyr N, Thiringer G (April 1977). "Comparison of rimiterol and terbutaline, given by aerosol, in a long-term study". Scandinavian Journal of Respiratory Diseases. 58 (2): 117–24. PMID 16339.
  • v
  • t
  • e
Adrenergics, inhalants
Short-acting β2 agonists
Long-acting β2 agonists
Ultra-long-acting β2 agonists
Other
GlucocorticoidsAnticholinergics/
muscarinic antagonistMast cell stabilizersXanthinesEicosanoid inhibition
Leukotriene antagonists
Arachidonate 5-lipoxygenase inhibitors
Thromboxane receptor antagonists
Non-xanthine PDE4 inhibitors
Others/unknownCombination products
  • v
  • t
  • e
α1
Agonists
Antagonists
α2
Agonists
Antagonists
β
Agonists
Antagonists
  • See also: Receptor/signaling modulators
  • Dopaminergics
  • Serotonergics
  • Monoamine reuptake inhibitors
  • Monoamine releasing agents
  • Monoamine metabolism modulators
  • Monoamine neurotoxins
Stub icon

This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e